Summary Keywords drug-repositioning, thyroid-cancer, anti-diabetic, metformin, diabetes Citation Greco A, Coperchini F, Croce L, Magri F, Teliti M and Rotondi M (2023) Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs
Ongoing follow-up appointments allow providers to review progress, answer questions, and make adjustments when clinically appropriate
Considering that Ibutamoren MK 677 and Ipamorelin were designed for medical use, their recommended dosages were small
Current Litigation GLP-1 lawsuits are being centralized in the Eastern District of Pennsylvania under MDL 3094
Life gets complicated
It starts with BPC-157, a peptide naturally present in gastric juices